These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25874545)

  • 21. Tuberculosis retreatment 'others' in comparison with classical retreatment cases; a retrospective cohort review.
    Nabukenya-Mudiope MG; Kawuma HJ; Brouwer M; Mudiope P; Vassall A
    BMC Public Health; 2015 Sep; 15():840. PubMed ID: 26330223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
    Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
    J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delay before drug susceptibility testing among patients with presumptive multidrug-resistant tuberculosis in Gujarat, India.
    Shewade HD; Shringarpure KS; Parmar M; Patel N; Kuriya S; Shihora S; Ninama N; Gosai N; Khokhariya R; Popat C; Thanki H; Modi B; Dave P; Baxi RK; Kumar AMV
    Trans R Soc Trop Med Hyg; 2018 Nov; 112(11):500-508. PubMed ID: 30137546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
    Kim S; Lee H; Park HY; Jeon K; Huh HJ; Lee NY; Jeong BH
    Respir Med; 2017 Dec; 133():6-11. PubMed ID: 29173450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain
    Timire C; Sandy C; Kumar AMV; Ngwenya M; Murwira B; Takarinda KC; Harries AD
    Int J Infect Dis; 2019 Apr; 81():236-243. PubMed ID: 30776546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M; Tayyaba U
    Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
    Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
    BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study.
    Habimana-Mucyo Y; Dushime A; Migambi P; Habiyambere I; Semuto Ngabonziza JC; Decroo T
    Int Health; 2023 Jul; 15(4):357-364. PubMed ID: 35653710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.
    Goswami A; Chakraborty U; Mahapatra T; Mahapatra S; Mukherjee T; Das S; Das A; Dey SK; Ray S; Bhattacharya B; Pal NK
    PLoS One; 2014; 9(10):e109563. PubMed ID: 25289974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High mortality during tuberculosis retreatment at a Ghanaian tertiary center: a retrospective cohort study.
    Bouton TC; Forson A; Kudzawu S; Zigah F; Jenkins H; Bamfo TD; Carter J; Jacobson K; Kwara A
    Pan Afr Med J; 2019; 33():111. PubMed ID: 31489089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes.
    Katende B; Esterhuizen TM; Dippenaar A; Warren RM
    Sci Rep; 2020 Feb; 10(1):1917. PubMed ID: 32024860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.
    Al-Hajoj S; Varghese B; Shoukri MM; Al-Omari R; Al-Herbwai M; Alrabiah F; Alrajhi AA; Abuljadayel N; Al-Thawadi S; Zumla A; Zignol M; Raviglione MC; Memish Z
    Antimicrob Agents Chemother; 2013 May; 57(5):2161-6. PubMed ID: 23459478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape.
    Albert H; Trollip AP; Seaman T; Abrahams C; Mole RJ; Jordaan A; Victor T; Hoosain E
    S Afr Med J; 2007 Sep; 97(9):858-63. PubMed ID: 17985057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.
    Menzies HJ; Moalosi G; Anisimova V; Gammino V; Sentle C; Bachhuber MA; Bile E; Radisowa K; Kachuwaire O; Basotli J; Maribe T; Makombe R; Shepherd J; Kim B; Samandari T; El-Halabi S; Chirenda J; Cain KP
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1026-33. PubMed ID: 25189548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of UDST: A step forward to end TB.
    Kumar Sharma A; Vijay S; Mathur RB; Meena H
    Indian J Tuberc; 2020 Apr; 67(2):213-215. PubMed ID: 32553314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
    Sharma SK; Chaubey J; Singh BK; Sharma R; Mittal A; Sharma A
    Int J Tuberc Lung Dis; 2017 Oct; 21(10):1112-1117. PubMed ID: 28911354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.